Can TRT Lower Fertility Even With Normal Testosterone?

Understand

Overview

This is one of the more confusing paradoxes in the whole field of testosterone replacement therapy: a man on TRT gets a blood test result that looks textbook-perfect — total testosterone in the ideal range, sometimes even in the upper part of it — while a semen analysis shows a drastically reduced sperm count or their complete absence (azoospermia). Intuitively this seems contradictory: if there's plenty of testosterone, fertility should be fine. In reality that reasoning is wrong in the context of TRT, and the explanation lies in the fact that testosterone concentration measured in blood serum and testosterone concentration inside the testis itself are two entirely different, only loosely connected quantities once exogenous testosterone enters the picture.

To understand this paradox, you need to go back to how the body regulates testosterone and sperm production in the first place. This is handled by the hypothalamic-pituitary-gonadal axis (the HPG axis). The hypothalamus pulsatile secretes the hormone GnRH, which stimulates the pituitary to secrete two hormones: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). LH stimulates Leydig cells in the testes to produce testosterone right there, locally, inside testicular tissue. FSH, together with that locally high testosterone concentration, supports Sertoli cells, which physically "nurture" maturing sperm in the seminiferous tubules. The whole system works on a negative feedback basis — when the hypothalamus and pituitary "see" a high testosterone level in the blood, they scale back GnRH and LH secretion, judging that there's already enough of the hormone.

The problem is that the brain doesn't distinguish testosterone produced by a man's own testes from testosterone delivered by an injection, gel, or patch as part of TRT — it only sees an elevated concentration in the blood and reacts identically, suppressing GnRH and, as a result, LH and FSH, sometimes almost to zero. Without an LH signal, Leydig cells stop being stimulated to produce testosterone locally. And it's exactly this local, intratesticular testosterone level — not the level measured in an arm vein — that proper spermatogenesis depends on. Under physiological conditions, intratesticular testosterone concentration is estimated to be dozens to as much as a hundred times higher than the concentration in blood serum. Testosterone supplied from outside as part of TRT circulates in the blood and effectively normalizes the lab result, but it doesn't recreate that extremely high, local intratesticular environment, because it doesn't reach it in sufficient concentration through general circulation, while local production is simultaneously switched off by LH suppression.

Evidence for this mechanism isn't merely theoretical. A classic 2005 study by Coviello and colleagues directly measured intratesticular testosterone concentration in healthy men subjected to hormonal suppression by exogenous testosterone, and showed that despite normal, even elevated, serum testosterone, intratesticular testosterone concentration dropped drastically as a result of LH suppression — while adding a low dose of hCG (a hormone that mimics LH's action) maintained it at a level close to normal despite ongoing suppression of the pituitary's own LH. This study, though conducted in healthy volunteers rather than long-term TRT patients, remains one of the best direct pieces of evidence that normalizing blood testosterone and normalizing the hormonal environment inside the testis are two independent phenomena during exogenous testosterone therapy.

In practical terms, this means that no standard blood panel ordered when monitoring TRT — total testosterone, free testosterone, LH, FSH — can on its own confirm or rule out preserved fertility. A normal, even optimal, blood testosterone result says nothing about the sperm count in semen. The only way to genuinely check this is a direct semen analysis (spermiogram) — subjective well-being, libido, or the mere fact of a "good" hormonal result don't substitute for it. That's why men actively planning to have children, considering or already on TRT, should treat a conversation about fertility as a separate, necessary part of care, independent of standard hormonal monitoring of therapy.

The good news is that in most men this effect is reversible after stopping TRT, though the process is measured in months, not weeks, and tends to be slower or incomplete in older men and after longer therapy duration. For men who want to continue TRT while preserving fertility, specific strategies are available — chiefly adding hCG, which mimics LH's action and allows intratesticular testosterone production to be maintained despite ongoing therapy, as well as non-suppressive alternatives such as SERMs (clomiphene, enclomiphene), which raise testosterone by stimulating a man's own hormonal axis instead of suppressing it. A detailed discussion of the mechanism behind reversibility, data on fertility-recovery timelines, and practical hCG dosing schedules in this context is available in our articles "TRT and Fertility" and "hCG During TRT — Fertility."